5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.
We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.